Pharma Journalist -

BioLight Life Sciences announced successful results from its glaucoma insert VS101 ("Eye-D latanoprost insert") Phase 1/2a clinical trial, which demonstrated its ability to lower…
Read More...

Medidata announced that BeiGene, a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, will expand…
Read More...

Pfizer Inc. and Basilea Pharmaceutica announced that they have completed the licensing agreement whereby Pfizer has obtained the exclusive commercialization rights in Europe to CRESEMBA…
Read More...

Oncology Venture AB and Novartis Pharma AG (Basel, Switzerland) have entered into an agreement providing Oncology Venture with an option right to  execute an exclusive license to…
Read More...

ModGene Pharma announced the issuance of US Patent 9,707,231, entitled "Compositions and Methods for Reduction of Amyloid-beta Load." The claims cover the use of an imatinib-related…
Read More...

Amgen and UCB announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologics License Application (BLA) for EVENITY (romosozumab) as a…
Read More...

Valeant Pharmaceuticals International announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in…
Read More...

Glenmark Pharmaceuticals, a global pharmaceutical company, announced that it has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma…
Read More...

Roche announced that OCREVUS (ocrelizumab) has been approved by the Australian Therapeutic Goods Administration (TGA) for the treatment of relapsing forms of multiple sclerosis (RMS)…
Read More...

Eli Lilly and Company has entered into a settlement agreement with generic companies to resolve pending patent litigation in the U.S. District Court for the Eastern District of Virginia…
Read More...